Our major research programme concerns the folding, stability and activity of proteins. We apply a broad multi-disciplinary approach that combines methods and ideas of molecular biology and physical-organic chemistry. We use techniques including protein engineering, DNA cloning, sequencing and mutagenesis, cell culture, gene and peptide synthesis, spectroscopy, rapid reaction techniques, multi-dimensional NMR (we have a 500, 600, 700 and an 800 MHz spectrometers) and x-ray protein crystallography.

Current major projects include: protein folding, misfolding and disease; drug discovery; and structure-activity relationships of proteins involved in cancer and disease.

Although now emeritus, I am still fully active in research with long term funding, including an MRC Programme Grant.

Publications

A Transient and Low-Populated Protein-Folding Intermediate at Atomic Resolution
DM Korzhnev, TL Religa, W Banachewicz, AR Fersht, LE Kay
Science
(2010)
329
Refolding the engrailed homeodomain: Structural basis for the accumulation of a folding intermediate
ME McCully, DAC Beck, AR Fersht, V Daggett
Biophys J
(2010)
99
The human peripheral subunit-binding domain folds rapidly while overcoming repulsive Coulomb forces.
E Arbely, H Neuweiler, TD Sharpe, CM Johnson, AR Fersht
Protein Science
(2010)
19
Highest paraoxonase turnover rate found in a bacterial phosphotriesterase variant
L Briseño-Roa, Z Oliynyk, CM Timperley, AD Griffiths, AR Fersht
Protein engineering, design & selection : PEDS
(2010)
24
S100 proteins interact with the N-terminal domain of MDM2
J van Dieck, JK Lum, DP Teufel, AR Fersht
FEBS letters
(2010)
584
Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.
S Rajagopalan, A Andreeva, TJ Rutherford, AR Fersht
Proceedings of the National Academy of Sciences
(2010)
107
Transdisciplinary EU science institute needs funds urgently
JW Vasbinder, B Andersson, WB Arthur, M Boasson, R de Boer, JP Changeux, E Domingo, M Eigen, A Fersht, D Frenkel, M Rees, T Groen, R Huber, T Hunt, J Holland, R May, E Norrby, P Nijkamp, JM Lehn, R Rabbinge, M Scheffer, P Schuster, I Serageldin, J Stuip, J de Vries, W van Vierssen, R Willems
Nature
(2010)
463
The Tumor Suppressor p53: From Structures to Drug Discovery
AC Joerger, AR Fersht
Cold Spring Harbor perspectives in biology
(2010)
2
Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
J van Dieck, T Brandt, DP Teufel, DB Veprintsev, AC Joerger, AR Fersht
Oncogene
(2010)
29
Engineering a two-helix bundle protein for folding studies
CA Dodson, N Ferguson, TJ Rutherford, CM Johnson, AR Fersht
Protein engineering, design & selection : PEDS
(2010)
23